Metabolic syndrome is defined by the presence of at least two of the following five criteria: abdominal perimeter\> 94 cm in men, 80 cm in women, high triglycerides, low HDL cholesterol, HTA and hyperglycemia. The metabolic syndrome can lead to ultrasound hepatic steatosis in 20 to 40% of cases depending on the population studied (overweight vs obesity). What is the impact of this syndrome on pancreatic echogenicity?
Little is known about the pathogenesis of the fatty pancreas. Fat can replace acinar cells and / or pancreatic endocrine cells (1). To date, there are no biomarkers allowing the detection of a fatty pancreas. It appears that older age, male, obesity, alcohol consumption, high triglycerides, high ALT, diabetes or insulin resistance, fatty liver and metabolic syndrome are risk factors for a fatty pancreas (2,3,4).To the investigator's knowledge, these different factors have not been evaluated on the impact of pancreatic echogenecity in endosonography. The objective of this study is to correlate the factors making up the metabolic syndrome with pancreatic echogenecity.
Study Type
OBSERVATIONAL
Enrollment
97
Echo-endoscopy ultrasound is an examination that presents little risk. However, any medical act, exploration, intervention even conducted under conditions of competence and safety in accordance with current data of medicine and the regulations in force, conceals a risk of complications. In particular, esophageal perforations can occur. They are often favored by underlying lesions (tumor, diverticulum, anatomical variants ...). Other complications are possible such as cardiovascular, respiratory or infectious disorders, as with any anesthesia.
Polyclinique du Beaujolais
Arnas, France
Clinique du Val d'Ouest
Écully, France
Hôpital privé Jean Mermoz
Lyon, France
Clinique du Trocadéro
Paris, France
Clinique des Portes du Sud
Correlation of the pancreatic echogenicity by endoscopic ultrasound with the metabolic syndrome
Three categories of echogenicity have been defined. The presence of one or more factors of the metabolic syndrome was correlated with the category of pancreatic echogenicity defined by the experts
Time frame: During the reading of the echo-endoscopic procedure
Comparaison of the echogenicity of the pancreas with respect to the liver and to the spleen will be made.
The pancreatic echogenicity score will be assessed with the following criteria 1. The visibility of Wirsung in three categories: excellent, average, poor 2. that of the contours in 3 categories good or average or poor visualization of the splenic vein 3. that of the parenchyma in 3 categories: normal, brilliant, not too obstructing the visualization of the Wirsung and the splenic vein, very promising embarrassing the visualization of the Wirsung and the splenic vein 4. with in addition a -heterogeneous or - homogeneous item for the parenchyma.
Time frame: During the reading of the echo-endoscopic procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Vénissieux, France